We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Apolipoprotein A-IV inhibits experimental colitis.
- Authors
Vowinkel, Thorsten; Mori, Mikiji; Knieglstein, Christian F.; Russell, Janice; Saijo, Fumito; Bharwani, Sulaiman; Turnage, Richard H.; Davidson, W. Sean; Tso, Patrick; Granger, D. Neil; Kalogeris, Theodore J.
- Abstract
The antiatherogenic properties of apoA-IV suggest that this protein may act as an anti-inflammatory agent. We examined this possibility in a mouse model of acute colitis. Mice consumed 3% dextran sulfate sodium (DSS) in their drinking water for 7 days, with or without daily intraperitoneal injections of recombinant human apoA-IV. apoA-IV significantly and specifically delayed the onset, and reduced the severity and extent of, DSS-induced inflammation, as assessed by clinical disease activity score, macroscopic appearance and histology of the colon, and tissue myeloperoxidase activity. Intravital fluorescence microscopy of colonic microvasculature revealed that apoA-IV significantly inhibited DSS-induced leukocyte and platelet adhesive interactions. Furthermore, apoA-IV dramatically reduced the upregulation of P-selectin on colonic endothelium during DSS-colitis. apoA-IV knockout mice exhibited a significantly greater inflammatory response to DSS than did their WT littermates; this greater susceptibility to DSS-induced inflammation was reversed upon exogenous administration of apoA-IV to knockout mice. These results provide the first direct support for the hypothesis that apoA-IV is an endogenous anti-inflammatory protein. This anti-inflammatory effect likely involves the inhibition of P-selectin-mediated leukocyte and platelet adhesive interactions.
- Subjects
APOLIPOPROTEINS; COLITIS; MICE; ANTI-inflammatory agents; ENDOTHELIUM; LEUCOCYTES
- Publication
Journal of Clinical Investigation, 2004, Vol 114, Issue 2, p260
- ISSN
0021-9738
- Publication type
Article
- DOI
10.1172/JCI200421233